These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10351898)

  • 21. Experts clash over likely impact of cheap AIDS drugs in Africa.
    Wadman M
    Nature; 2001 Apr; 410(6829):615-6. PubMed ID: 11287906
    [No Abstract]   [Full Text] [Related]  

  • 22. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxyribonucleoside 2'- or 3'-mixed disulfides: prodrugs to target ribonucleotide reductase and/or to inhibit HIV reverse transcription.
    Roy B; Chambert S; Lepoivre M; Aubertin AM; Balzarini J; Décout JL
    J Med Chem; 2003 Jun; 46(13):2565-8. PubMed ID: 12801219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular bases in the search for drugs for treating AIDS. Achievements and possible prospects].
    Kraevskiĭ AA
    Mol Biol (Mosk); 1999; 33(3):343-52. PubMed ID: 10519109
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV drug development: the next 25 years.
    Flexner C
    Nat Rev Drug Discov; 2007 Dec; 6(12):959-66. PubMed ID: 17932493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of ribonucleotide reductase activity by IC202C.
    Iijima M; Someno T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 2001 Aug; 54(8):682-3. PubMed ID: 11592505
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiretroviral rounds. Virologic failure: true or false?
    Gallant JE; Shafer R
    AIDS Clin Care; 2005 Sep; 17(9):84-5. PubMed ID: 16201048
    [No Abstract]   [Full Text] [Related]  

  • 28. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.
    Hupfeld J; Efferth T
    In Vivo; 2009; 23(1):1-6. PubMed ID: 19368117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyurea may enhance effectiveness of anti-HIV regimens presently in use.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(2):1-2. PubMed ID: 11365124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance tests to improve therapy. More specific use of AIDS drugs].
    Paukstadt W
    MMW Fortschr Med; 1999 Sep; 141(37):18. PubMed ID: 10897968
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multiple benefits associated with HIV drug-resistance mutation M184V.
    Bean P
    Am Clin Lab; 2002 Mar; 21(2):16-8. PubMed ID: 11993249
    [No Abstract]   [Full Text] [Related]  

  • 33. [No comparison with NRTI. Tenofovir is robust against resistance trouble].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():65. PubMed ID: 12043079
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunologic restoration in patients with AIDS. Requiem for prophylaxis].
    Peña JM; Miró JM
    Med Clin (Barc); 1999 Oct; 113(10):375-8. PubMed ID: 10562941
    [No Abstract]   [Full Text] [Related]  

  • 35. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS researchers seek criteria for vaccines.
    Check E
    Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV-1 drug resistance among untreated patients in India: Current status.
    Pachamuthu B; Shanmugam S; Nagalingeswaran K; Solomon SS; Solomon S; Solomon S
    J Postgrad Med; 2006; 52(3):183-6. PubMed ID: 16855318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infrequent deletion in 67 codon in HIV reverse transcriptase in antiretroviral treatment failure].
    Giri J; Jáuregui Rueda H; Monticelli A; Pirola DA; Planes N
    Medicina (B Aires); 2001; 61(2):193-5. PubMed ID: 11374145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of ribonucleotide reductase reduces neointimal formation following balloon injury.
    Henry JC; Bonar MM; Kearns PN; Cui H; Mutchler MM; Martin MV; Orsini AR; Elford HL; Bush CA; Zweier JL; Cardounel AJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):70-6. PubMed ID: 15814568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The answers continue.
    Laurence J
    AIDS Read; 1999; 9(1):7-8. PubMed ID: 12728874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.